홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

5-tert-Butoxycarbonylamino-2-chloroisonicotinic acid → 6-chloro-2-(5-fluoro-2-methylphenyl)-1,7-naphthyridin-4(1H)-one

HRID 468847
인쇄

반응식

HRID 468847 반응식
C(OC([NH:8][C:9]1[C:14]([C:15](O)=[O:16])=[CH:13][C:12]([Cl:18])=[N:11][CH:10]=1)=O)(C)(C)C.[F:19][C:20]1[CH:21]=[CH:22][C:23]([CH3:29])=[C:24]([C:26](=O)[CH3:27])[CH:25]=1>>[Cl:18][C:12]1[CH:13]=[C:14]2[C:9](=[CH:10][N:11]=1)[NH:8][C:26]([C:24]1[CH:25]=[C:20]([F:19])[CH:21]=[CH:22][C:23]=1[CH3:29])=[CH:27][C:15]2=[O:16]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 105641445-tert-Butoxycarbonylamino-2-chloroisonicotinic acidHCID 153354205'-Fluoro-2'-methylacetophenone

생성물 1

HCID 866749486-chloro-2-(5-fluoro-2-methylphenyl)-1,7-naphthyridin-4(1H)-one수율 24%

실험 절차

The title compound was prepared following a procedure similar to example 121 using 5-(tert-butoxycarbonylamino)-2-chloroisonicotinic acid (505 mg, 1.85 mmol) and 5′-fluoro-2′-methylacetophenone (566 mg, 3.72 mmol) to afford the impure title compound as a beige solid (128 mg), used without further purification. LCMS: M+H+=289 & 291.

후처리

  1. customThe title compound was prepared

출처 및 근거

ORD 기록
ord-ce8c7e5988fa43c395425994c5f715fa
출처 데이터셋
uspto-grants-2014_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08623889B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트